"Nebulized exosome administration reduces neuroinflammation markers and improves cerebral oxygenation via the olfactory route — bypassing the blood-brain barrier."Exosomes · neuroinflammation · olfactory
02
Longevity Science
Category · Brain & Cognition
Brain, cognition and neuroinflammation. The frontier of neuroprotection.
An editorial review of evidence on nebulized exosomes (ExBrain protocol), neuroprotective peptides (Cerebrolysin, Semax, BPC-157), intravenous NAD+, and cerebral nutraceuticals applied to chronic neuroinflammation management, mild cognitive impairment, brain fog, post-concussion syndrome, and cognitive performance optimization in the second half of life.
Conditions we address
Applicable both to subjective cognitive complaint and to optimization of intellectual performance. Each case requires baseline neurocognitive evaluation and ruling out conventionally treatable causes.
- Mild cognitive impairment (MCI)
- Brain fog (post-COVID or chronic)
- Prevention in patients with Alzheimer's risk
- Post-concussion syndrome
- Cognitive optimization in high performance
- Mild anxiety and mood disorders
- Sleep disorders with cognitive impact
- Chronic mental fatigue
Protocol Components
An integrated approach to brain health
The brain ages through inflammation, hypoperfusion, metabolic deficit, and loss of synaptic plasticity. The protocol intervenes each vector with the most-studied therapy available.
01
ExBrain — Nebulized Exosomes
Wellness Care's exclusive protocol for neuroinflammation management through nebulized exosome administration with olfactory CNS access.
Exosomes are extracellular vesicles concentrated in anti-inflammatory factors and regulatory microRNAs. Nebulized administration bypasses the blood-brain barrier using the olfactory route as direct CNS access. Emerging literature (Journal of Neuroinflammation 2024) suggests reduced neuroinflammation, improved cerebral oxygenation, and microvascular recovery. Clinical use in humans is performed under individual medical assessment within the applicable regulatory framework.
02
Neuroprotective Peptides
Cerebrolysin, Semax, and BPC-157 — bioactive peptides with documented clinical literature in neurogenesis, neuroprotection, and synaptic plasticity.
Cerebrolysin has regulatory approval in over 50 countries as a neuroprotective agent with literature in stroke, vascular dementia, and TBI. Semax is a Russian nootropic peptide with documented clinical use since the 1980s, particularly for cognitive function and stress resistance. BPC-157 is a research peptide with robust preclinical literature in neuroprotection, neurogenesis, and nervous tissue repair. See peptide science.
03
Specialized IV Therapies
Intravenous NAD+, high-performance IV glutathione, parenteral B-complex, and specific antioxidants for cerebral mitochondrial health.
NAD+ is an essential cofactor for neuronal mitochondrial energy production and for sirtuin activity involved in DNA repair. IV administration optimizes systemic bioavailability. IV Glutathione is the master intracellular antioxidant — neutralizes cerebral oxidative stress and supports phase II hepatic detoxification. Literature sustains measurable neuroprotective effects, mitochondrial improvement, and reduced cerebral oxidative stress (Nature Neuroscience 2023).
04
Advanced Cerebral Nutraceuticals
Pharmaceutical-grade EPA/DHA omega-3, phosphatidylserine, bioavailable curcumin, magnesium L-threonate, vitamin D3+K2, and methylated B-complex.
Oral supplementation sustains the changes achieved with intensive interventions. Each nutraceutical is selected for documented bioavailability, analytical purity, and specific clinical evidence for brain function. The formulation is personalized based on the patient's nutritional biomarkers (vitamin D, homocysteine, folate, B12, omega-3 index).
Expected clinical outcomes
- Documented improvement in memory and concentration
- Greater mental clarity and processing speed
- Reduction of neuroinflammation in biomarkers
- Better sleep quality and architecture
- Reduced chronic mental fatigue
- Better management of cognitive stress
- Protection against age-associated cognitive decline
- Support of adult neurogenesis
Scientific support
Cutting-edge research in neuroprotection
Each protocol component is supported by recent indexed scientific literature. The selection follows the strength of evidence, not commercial novelty.
Key references
- Journal of Neuroinflammation (2024). Exosome nebulization in neuroinflammation — Documented significant reduction of neuronal inflammatory markers and improved cerebral oxygenation with nebulized exosome administration.
- Journal of Neuroscience Research (2023). Efficacy of neuroprotective peptides — Clinical studies with peptides such as BPC-157 and Cerebrolysin evidencing improvements in cognitive function and neurogenesis promotion.
- Nature Neuroscience (2023). NAD+ supplementation and brain health — Demonstrated neuroprotective effects with improved neuronal mitochondrial function and reduced cerebral oxidative stress.
- Lancet Neurology (2023). Mild cognitive impairment — intervention windows — Established the importance of multimodal intervention in mild cognitive impairment before progression to dementia.
Safety & monitoring
Every protocol under specialized medical supervision
- Baseline cognitive evaluation with standardized neuropsychological battery
- Analysis of neuroinflammatory and cerebral metabolic biomarkers
- Ruling out conventionally treatable causes before starting the protocol
- Neuropsychological follow-up at 3, 6 and 12 months with remeasurements
- Personalized protocol adjustments based on individual clinical response
- Review of drug interactions and specific contraindications
- Compliance with Colombia's INVIMA regulatory framework
Frequently asked questions
Essentials before deciding
What is the ExBrain protocol and how do nebulized exosomes work?
ExBrain is Wellness Care's exclusive protocol for neuroinflammation through nebulized exosomes. The nebulized route bypasses the blood-brain barrier via the olfactory route. Emerging literature suggests reduced neuroinflammation, improved cerebral oxygenation, and microvascular recovery.
How long to see results in cognitive function?
Initial subjective changes in 2-4 weeks. Measurable changes on neuropsychological evaluations typically between months 3-6. Follow-up continues for 12 months.
Is the use of neuroprotective peptides safe?
Cerebrolysin has approval in 50+ countries. Semax has clinical use since the 1980s. BPC-157 is research with robust preclinical literature. Clinical use in Colombia under individual medical assessment within the applicable regulatory framework.
Can this protocol prevent neurodegenerative diseases?
Current medicine offers no interventions that prevent specific neurodegenerative diseases with certainty. However, modulating neuroinflammation, optimizing metabolism, and activating neurotrophic pathways reduce modifiable risk factors. The protocol is preventive strategy, not curative treatment.
Regulatory framework
The use of exosomes, peptides, and intravenous therapies in humans in Colombia is performed under individual medical assessment and within the applicable regulatory framework of INVIMA.
Featured evidence
The papers that support
The papers that support
clinical neuroprotection
Three publications guiding the clinical reading of the ExBrain protocol and neuromodulation with peptides.
"Cerebrolysin holds regulatory approval in more than 50 countries and clinical literature in stroke, vascular dementia and traumatic brain injury."Cerebrolysin · 50+ countries · stroke
"IV NAD+ demonstrated neuroprotective effects with improved neuronal mitochondrial function and reduced cerebral oxidative stress."NAD+ · mitochondria · neuroprotection
The real promise
Your brain is the only organ that isn't replaced. Protecting it isn't optional — it's the decision that defines the next two decades of your cognitive and emotional life.
Mental clarity, sustained focus, and preserved memory are not privileges of youth — they are achievable clinical objectives when intervention happens early, with the right combination of neuroprotection, inflammation modulation, and metabolic support.
Does your cognitive performance deserve more?
Begin with a cognitive evaluation
In 60 minutes we do a baseline cognitive evaluation, review neuroinflammatory biomarkers, and your cerebral metabolic profile. We explain what the evidence says for your case and design a personalized neuroprotection protocol under individual medical criteria.